About Ginkgo Bioworks
Ginkgo Bioworks is a company based in Boston (United States) founded in 2008 by Austin Che, Tom Knight, and Barry Canton.. Ginkgo Bioworks has raised $795.75 million across 23 funding rounds from investors including Illumina, T. Rowe Price and General Atlantic. The company has 834 employees as of December 31, 2024. Ginkgo Bioworks has completed 12 acquisitions, including Altar, Beacon Testing and Bitome. Ginkgo Bioworks offers products and services including AI Models, Data Generation, and Lab Automation. Ginkgo Bioworks operates in a competitive market with competitors including Amyris, Inscripta, Pivot Bio, Syngenta and Asimov, among others.
- Headquarter Boston, United States
- Employees 834 as on 31 Dec, 2024
- Founders Austin Che, Tom Knight, Barry Canton
- Stage Public
-
Sectors
HealthcareAgriculture
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Ginkgo Bioworks Holdings, Inc.
-
Annual Revenue
$227.04 M-9.71as on Dec 31, 2024
-
Net Profit
$-547.03 M38.73as on Dec 31, 2024
-
EBITDA
$-397.28 M33.86as on Dec 31, 2024
-
Total Equity Funding
$795.75 M (USD)
in 23 rounds
-
Latest Funding Round
-
Investors
Illumina
& 23 more
-
Employee Count
834
as on Dec 31, 2024
-
Investments & Acquisitions
Altar
& 11 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Ginkgo Bioworks
Ginkgo Bioworks is a publicly listed company on the NYSE with ticker symbol DNA in USA, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Ginkgo Bioworks
Ginkgo Bioworks offers a comprehensive portfolio of products and services, including AI Models, Data Generation, and Lab Automation. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI models for enhancing research and development projects
Tools for creating high-quality datasets in biotech applications
Systems for scalable lab processes in scientific research
Unlock access to complete
Unlock access to complete
Senior Team
52 people
Software Development Team
36 people
Leadership Team
28 people
Sales and Marketing
21 people
Creative and Marketing Team
12 people
Finance and Accounting
11 people
Operations Team
10 people
Product Management Team
8 people
Unlock access to complete
Funding Insights of Ginkgo Bioworks
Ginkgo Bioworks has successfully raised a total of $795.75M across 23 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 23
- Last Round Last Round
-
First Round
First Round
(01 Jun 2009)
- Investors Count 24
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2023 | Amount | Grant - Ginkgo Bioworks | Valuation |
investors |
|
| Aug, 2023 | Amount | Grant - Ginkgo Bioworks | Valuation |
investors |
|
| Jun, 2023 | Amount | Grant - Ginkgo Bioworks | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ginkgo Bioworks
Ginkgo Bioworks has secured backing from 24 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Illumina, T. Rowe Price and General Atlantic. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity fund focused on global markets
|
Founded Year | Domain | Location | |
|
Private investment firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Early-stage startups are accelerated via funding and educational programs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ginkgo Bioworks
Ginkgo Bioworks has strategically engaged in corporate development activities, having acquired 12 companies. Notable acquisitions include Altar, Beacon Testing and Bitome. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Organizations are supported in scaling COVID-19 testing operations.
|
2020 | ||||
|
Gene therapies for a broad range of diseases are developed.
|
2020 | ||||
|
CRISPR-based COVID-19 molecular testing devices are manufactured.
|
2020 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Ginkgo Bioworks
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ginkgo Bioworks Comparisons
Competitors of Ginkgo Bioworks
Ginkgo Bioworks operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Inscripta, Pivot Bio, Syngenta and Asimov, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of renewable products for industrial solutions
|
|
| domain | founded_year | HQ Location |
Speech recognition solutions are provided by Inscripta for healthcare professionals.
|
|
| domain | founded_year | HQ Location |
Nitrogen-fixing microbes for corn crop nutrition are developed and applied.
|
|
| domain | founded_year | HQ Location |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| domain | founded_year | HQ Location |
Provider of integrated suite for advanced genetic design and manufacturing
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ginkgo Bioworks
Frequently Asked Questions about Ginkgo Bioworks
When was Ginkgo Bioworks founded?
Ginkgo Bioworks was founded in 2008 and raised its 1st funding round 1 year after it was founded.
Where is Ginkgo Bioworks located?
Ginkgo Bioworks is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is Ginkgo Bioworks a funded company?
Ginkgo Bioworks is a funded company, having raised a total of $795.75M across 23 funding rounds to date. The company's 1st funding round was a Grant of $649.99K, raised on Jun 01, 2009.
How many employees does Ginkgo Bioworks have?
As of Dec 31, 2024, the latest employee count at Ginkgo Bioworks is 834.
What is the annual revenue of Ginkgo Bioworks?
Annual revenue of Ginkgo Bioworks is $227.04M as on Dec 31, 2024.
What does Ginkgo Bioworks do?
Ginkgo Bioworks was founded in 2008 in Boston, United States. Operations focus on the biotechnology sector, where gene editing technologies are applied to develop cultured ingredients for agriculture. Microbes are engineered and produced to create products including flavors, fragrances, cosmetics, and sweeteners. Services extend to supporting industrial applications through synthetic biology methods.
Who are the top competitors of Ginkgo Bioworks?
What products or services does Ginkgo Bioworks offer?
Ginkgo Bioworks offers AI Models, Data Generation, and Lab Automation.
Is Ginkgo Bioworks publicly traded?
Yes, Ginkgo Bioworks is publicly traded on NYSE under the ticker symbol DNA.
How many acquisitions has Ginkgo Bioworks made?
Ginkgo Bioworks has made 12 acquisitions, including Altar, Beacon Testing, and Bitome.
Who are Ginkgo Bioworks's investors?
Ginkgo Bioworks has 24 investors. Key investors include Illumina, T. Rowe Price, General Atlantic, Gates Foundation, and HHS.
What is Ginkgo Bioworks's ticker symbol?
The ticker symbol of Ginkgo Bioworks is DNA on NYSE.
What is Ginkgo Bioworks's valuation?
The valuation of Ginkgo Bioworks is $4.2B as of Sep 2019.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.